Related Experiment Video
Updated: Jul 3, 2026

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice
Published on: January 9, 2019
Delayed electrical stimulation and BDNF application following induced deafness in rats
Bing-Nan Song1, Yong-Xin Li, De-Min Han
1Department of Otorhinolaryngology, Beijing Tongren Hospital, Capital Medical University, Beijing, PR China.
Delayed treatment with electrical stimulation (ES) and brain-derived neurotrophic factor (BDNF) in rats improves spiral ganglion cell survival and auditory sensitivity. The combination of ES and BDNF showed a synergistic protective effect, with peripheral processes being crucial for auditory function.
Area of Science:
- Neuroscience
- Otolaryngology
- Regenerative Medicine
Background:
- Sensorineural hearing loss is often associated with the degeneration of spiral ganglion neurons (SGNs).
- Current treatments for hearing loss have limitations, necessitating novel therapeutic strategies.
- Protecting SGNs is crucial for preserving auditory function and cochlear implant efficacy.
Purpose of the Study:
- To investigate the efficacy of delayed, combined intracochlear electrical stimulation (ES) and brain-derived neurotrophic factor (BDNF) delivery in preventing SGN degeneration.
- To determine the impact of this combined therapy on auditory sensitivity following induced deafness in rats.
- To explore the relationship between SGN survival, peripheral process integrity, and auditory function.
Main Methods:
- Rats were subjected to gentamicin+furosemide-induced deafness.
- 30 days post-deafening, intracochlear electrodes and drug-delivery systems were implanted.
- Continuous administration of BDNF or artificial perilymph (AP) was combined with or without ES for 28 days.
- Electrically evoked auditory brainstem responses (EABRs) and SGN/peripheral process density were assessed.
Main Results:
- Combined ES and BDNF treatment significantly improved EABR thresholds compared to control groups.
- Both ES and BDNF individually enhanced SGN and peripheral process survival.
- The combination of ES and BDNF demonstrated a synergistic protective effect, outperforming individual treatments.
- A functional relationship was established between EABR thresholds and SGN/peripheral process density.
Conclusions:
- Delayed, chronic intracochlear ES and continuous BDNF administration promote SGN survival and enhance auditory sensitivity in a rat model of deafness.
- The combination of ES and BDNF exerts a synergistic, rather than additive, protective effect.
- Peripheral processes of SGNs play a critical role in auditory sensitivity, potentially more so than SGN bodies.
More Related Videos
11:39Assessment of Audio-Tactile Sensory Substitution Training in Participants with Profound Deafness Using the Event-Related Potential Technique
Published on: September 7, 2022
10:50Behavioral Determination of Stimulus Pair Discrimination of Auditory Acoustic and Electrical Stimuli Using a Classical Conditioning and Heart-rate Approach
Published on: June 6, 2012